Replies to post #2309 on Cocrystal Pharma Inc (COCP)

[mick]

$COCP;Cocrystal Pharma Provides COVID-19 Impact Update on Development Programs
GlobeNewswire GlobeNewswire•May 11, 2020
– Company reprioritizes activities to accelerate development and provides next steps for advancing preclinical COVID-19 Coronavirus program –

– Discussions ongoing with potential strategic partners for COVID-19 Coronavirus program –

– Collaboration with Merck to discover and develop certain proprietary influenza A/B antiviral agents remains ongoing –

– Supply chain delay in fully owned influenza A virus program –

– Norovirus program on track to complete proof-of-concept animal study model in Q4 2020 –

https://finance.yahoo.com/news/cocrystal-pharma-provides-covid-19-120510979.html